导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.29% | 2565/4773 |
| 近一周 | -1.30% | 393/5462 |
| 近一月 | 0.12% | 656/5421 |
| 近一季 | -0.31% | 800/5209 |
| 近半年 | -5.32% | 2821/4920 |
| 近一年 | -1.40% | 2869/4366 |
| 近两年 | 23.53% | 2554/2954 |
| 近三年 | 14.11% | 1656/2253 |
| 成立以来 | 83.75% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.30% 974/4961 |
-10.38% 4095/5312 |
- - |
- - |
| 2025 | 2.93% 3158/4813 |
-2.42% 2884/3635 |
2.11% 1861/4076 |
1.88% 3856/4524 |
1.39% 1394/4813 |
| 2024 | 16.44% 812/3463 |
3.33% 592/2808 |
0.34% 629/3014 |
10.95% 2573/3129 |
1.23% 1101/3463 |
| 2023 | 12.84% 54/2656 |
8.63% 452/2280 |
3.20% 103/2385 |
3.73% 171/2515 |
-2.96% 560/2655 |
| 2022 | 1.85% 28/2207 |
4.04% 40/1919 |
-1.86% 1757/2016 |
-4.79% 64/2113 |
4.77% 509/2208 |
| 2021 | 22.54% 144/1822 |
9.04% 57/1255 |
1.50% 1049/1330 |
7.03% 198/1466 |
3.45% 430/1822 |
| 2020 | 4.31% 907/1250 |
-11.31% 834/1028 |
5.46% 880/1067 |
8.55% 706/1164 |
2.73% 970/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 天弘中证红利低波动100联接A VS. 长安沪深300非周期A(740101) |